ALVO Alvotech
$4.89▼ -1.01%
Healthcare
Other
After hours
$4.89▲ +0.00%
Oct 29, 4:00 PM ET
Volume 373.2K
Avg Volume (10D) 844.4K
Key Metrics & Fundamentals
Market Cap
$1.74B
P/E Ratio
33.8
Div Yield
0.00%
52W Range
2.94 - 7.92
% vs 50 MA
-7.87%
% vs 200 MA
16.13%
RSI-14
43.4
MACD Histogram
-0.0700
Beta (1Y vs SPY)
0.77
Free Cash Flow
-$64.56M
Gross Rev
$105.77M
Gross Profit
$53.58M
EBITDA
-$40.14M
COGS
$52.20M
Operating Exp
$65.28M
Operating Income
-$11.71M
EBIT
-$11.71M
Pretax Income
-$66.76M
Net Income
-$66.82M
Price & Volume History
Loading chart…
Recent News
Alvotech to Report Financial Results for the Nine-Month Period to September 30, 2026
GlobeNewswire · Oct 28, 2026 7:00 AM ET
Alvotech to Report Financial Results for the Nine-Month Period to September 30, 2026
GlobeNewswire · Oct 28, 2026 7:00 AM ET
Repligen (RGEN) Q3 Earnings and Revenues Surpass Estimates
Zacks · Oct 27, 2026 7:15 AM ET
New Strong Sell Stocks for October 21st
Zacks · Oct 21, 2026 5:43 AM ET
New Strong Sell Stocks for October 20th
Zacks · Oct 21, 2026 4:39 AM ET
Alvotech's Manufacturing Progress, Simponi Launch Potential Support Recovery, UBS Says
MT Newswires · Oct 20, 2026 12:11 PM ET
Sector Update: Healthcare Stocks Flat to Higher Premarket Tuesday
MT Newswires · Oct 20, 2026 9:20 AM ET
Alvotech Says FDA Approves New Manufacturing Process for Simlandi; Shares Rise Pre-Bell
MT Newswires · Oct 20, 2026 5:33 AM ET
Alvotech shares jump premarket after FDA approves new Simlandi process
Investing.com · Oct 20, 2026 5:22 AM ET
Alvotech receives FDA approval for new SIMLANDI® manufacturing process that more than doubles output per batch
GlobeNewswire · Oct 20, 2026 4:30 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See ALVO's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.